It is described in the literature that tumor cells can differentially secrete cytokines such as IL-35, IL-10 or TGF-β to induce a switch from N1 to N2 neutrophil phenotype in the early stages of cancer [71,72]. Here, TGFB1 is linked to neoplasm.